- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial.
September 10, 2020
Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy.
September 9, 2020
A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma.
September 9, 2020
Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
September 8, 2020
A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
September 8, 2020
A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma.
September 7, 2020
Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer.
September 7, 2020
The clinical significance of routine risk categorization in metastatic renal cell carcinoma and its impact on treatment decision-making: a systematic review.
September 4, 2020
Avelumab and axitinib combination therapy for the treatment of advanced renal cell carcinoma.
September 4, 2020
Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population.
September 4, 2020
Percutaneous microwave ablation of renal masses in a UK cohort.
September 3, 2020
Renal cell carcinoma: The role of radical surgery on different patterns of local or distant recurrence.
September 2, 2020
Neutrophil-to-mean platelet volume ratio as a new predictor for overall and cancer-specific survival in patients with localized clear cell renal cell carcinoma.
September 2, 2020
Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years.
September 2, 2020